EDUCATION
Phone: +49 89 895574 0
Email: info@labvantage-biomax.com
Website: www.labvantage-biomax.com
Dr. Klaus Heumann, CEO Biomax, editorializes in “A Matter of Timing” as published in Public Service Review: Health and Social Care, Issue 36, 2013, that time should be a metric used by healthcare organizations to measure success levels of standardized therapeutic procedures. Heumann suggests, “now is the time for transitioning to an innovative clinical system. Keeping the status quo is not an option, since time matters to the patient.” Read more.
Using the PEDANT™ Genome Analysis online service, organizations are able to quickly run comprehensive genome-wide sequence analysis for new isolates, identify taxonomic groups and develop molecular assays to detect specific bacteria. Convenient, affordable, comprehensive genome-wide sequence analysis in a few hours. Read more.
DSM AND BIOMAX EXTEND THE BIOXM PLATFORM TO STREAMLINE SYNTHETIC BIOLOGY PROJECTS
EFFICIENT COMPUTATIONAL SYSTEMS ALLOW STAFF TO FOCUS ON A PATIENT’S NEEDS
USING NEXT-GENERATION SEQUENCING DATA MAY BE MORE DIFFICULT THAN GETTING IT
NEWS
In collaboration with DSM, Biomax has extended the BioXM™ platform to the field of synthetic biology. Relying on three components,1) DNA Parts Repository, 2) Construct Building, and 3) Data Tracking and Knowledge Management Center, SYNOP-X™ (SYNthetic Biology OPen eXchange) allows the efficient exchange of information among the synthetic biology community. See the poster. Or visit the Biomax Synthetic Biology Web page here.
APPLICATIONS
VISIT THE BIOMAX BOOTH (HALL 9/STAND C35/7) AT BIOTECHNICA, OCTOBER 8–10, IN HANNOVER
EPO PATENT INFORMATION CONFERENCE 2013, BOLOGNA, ITALY
Dr. Philipp Krubasik will give a presentation, “Patient stratification for personalized medicine in a clinical center of excellence” at the meeting’s 'Personalized Medicine Technologies Marketplace.' Send an email to info@labvantage-biomax.com if you would like a copy of his presentation after the event. Find out more about BIOTECHNICA here.
Biomax is attending the EPO Patent Information Conference in Bologna, October 22–24. Please visit our booth to learn more about advancing informatics from 'searching as a service' to 'knowledge as a service.' Get more information about the conference here.
UNSUBSCRIBE
BIOMAX PROVIDES GENOME-WIDE SEQUENCE ANALYSIS OF MICROBES WITH EASY-ACCESS TOOL
DR. HEUMANN DELIVERS MASTER CLASS AT THE UK DIGITAL NHS, BARBICAN, LONDON
Biomax, BioXM, Pedant-Pro and PEDANT are registered trademarks of Biomax Informatics AG in Germany and other countries. Viscovery is a registered trademark of Viscovery Software GmbH. Registered trademarks used in this document or attachments, even when not specifically marked as such, are not to be considered unprotected by law.
BIOMAX INFORMATICS AG
ROBERT-KOCH-STR.2
D-82152 PLANEGG,
GERMANY
Titled, “Next-Generation Health Informatics,” Dr. Heumann’s master class at Digital NHS (September 19) will explore the ins and outs of transitioning a clinic to a knowledge-based patient stratification strategy, using an end-to-end case study in COPD. Send an email to info@labvantage-biomax.com if you would like a copy of the presentation following the event.
Bioinformatics Professor Dmitrij Frishman, Technische Univerität Mϋnchen, examines challenges and trends in NGS analysis. A rapidly increasing array of tools, pipelines, management systems, apps and reviews are flooding the NGS analysis tools space. Dr. Frishman, also a founder of Biomax, discusses navigating the tool space as well as obtaining and using NGS data optimally. Read more.